Skip to content

Cabaletta Bio, Inc. (CABA) — Institutional Holders & Catalysts | BiotechEdge

Catalysts Convergence Squeeze Signals Runway Insiders Research

Sign In Start Free Trial

Home›Companies›Cabaletta Bio, Inc. (CABA)

Cabaletta Bio, Inc.

CABA

Held by 1 specialist biotech fund

1 fund opened new positions.

Share

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

1.5/10

1 fund opened new positions

B

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback Terms Privacy Disclaimer

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Cormorant Asset ManagementNew

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/ACommodore Capital4.4%Feb 14, 2024

SC 13GCommodore Capital5.0%Jan 13, 2023

SC 13G/ARedmile Group2.5%Feb 14, 2022

SC 13GRedmile Group5.7%Feb 16, 2021

Position Details

Cormorant Asset ManagementNEWFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

AAVXF1 fund ALMS1 fund AMLX1 fund ARQT1 fund ASND1 fund AXSM1 fund BIOA1 fund BHVN1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts: